Related Experiment Video
Updated: Jul 11, 2026

14:14
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
14.6K
Towards a More Standardized Bicuspid Aortic Valve Repair: Rationale and Design of the CONTOUR Trial
Evaldas Girdauskas1,2, Sina Stock1, Daniel Hofbauer1
1Department of Cardiovascular and Thoracic Surgery, University Hospital Augsburg, Augsburg 86156, Germany.
Summary
The CONTOUR trial compares internal vs. external annuloplasty for aortic valve repair in bicuspid aortic valve (BAV) patients with aortic regurgitation (AR). Results will guide standardized repair techniques and improve patient outcomes.
Area of Science:
- Cardiovascular Surgery
- Medical Devices
- Clinical Trials
Background:
- Aortic valve repair is underutilized in young patients with bicuspid aortic valve (BAV) and aortic regurgitation (AR).
- Lack of standardization in current repair techniques leads to high rates of AR recurrence and reoperation.
- Stabilizing the BAV annulus is a critical, controversial aspect of aortic valve repair.
Purpose of the Study:
- To compare the effectiveness of two aortic valve annuloplasty concepts in BAV patients with AR.
- To assess the ability of internal vs. external annuloplasty to create symmetric BAV geometry post-repair.
- To evaluate the impact of different annuloplasty techniques on AR recurrence and reoperation rates.
Main Methods:
- The CONTOUR trial is a multicenter randomized controlled trial (RCT) involving 100 BAV AR patients.
- Patients are randomized to receive either internal HAART 200 annuloplasty or external Extra Aortic ring annuloplasty.
- 4D flow MRI will assess hemodynamic profiles and regurgitation fraction at baseline, discharge, and 1-year follow-up.
Main Results:
- The CONTOUR trial is the first RCT to directly compare two distinct annuloplasty techniques for BAV repair.
- The study aims to determine which technique is more effective in achieving symmetric BAV geometry and superior repair outcomes.
- Primary endpoints include postoperative reduction in flow eccentricity and 1-year regurgitation fraction.
Conclusions:
- Study findings are anticipated to significantly impact aortic valve repair practices for BAV patients with AR.
- Results are expected to contribute to refining guideline recommendations for managing BAV-associated AR.
- The trial seeks to establish a more standardized and effective approach to aortic valve repair.

